FDA Approves Umbralisib (Ukoniq) for Two Lymphomas ...Middle East

Medscape - News
The new drug has been granted an accelerated approval for use in patients with refractory or relapsed marginal zone lymphoma and follicular lymphoma. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Umbralisib (Ukoniq) for Two Lymphomas )

Apple Storegoogle play

Also on site :

Most viewed in News